The price of Vyvanse can vary significantly based on factors such as dosage, insurance coverage, and pharmacy. A 30-day supply of Vyvanse (lisdexamfetamine dimesylate) for ADHD can range from approximately $200 to over $400 without insurance [1].
How much does Vyvanse cost with insurance?
Insurance coverage greatly impacts Vyvanse pricing. Many insurance plans offer a lower co-pay for Vyvanse, potentially reducing the out-of-pocket cost to between $10 and $50 for a 30-day supply [1]. However, this depends on the specific formulary and deductible of the insurance plan. Patients are advised to check with their insurance provider for precise cost information.
Are there coupons or discounts for Vyvanse?
Manufacturer-sponsored savings programs and discount cards can help lower the cost of Vyvanse. For eligible commercially insured patients, savings programs may reduce the monthly cost to as little as $30 [1]. These programs are typically available through the Vyvanse manufacturer's website.
What is the difference between Vyvanse and Adderall prices?
Both Vyvanse and Adderall are stimulant medications used to treat ADHD, but their prices can differ. Vyvanse is a prodrug that is converted to dextroamphetamine in the body, and it is generally considered more expensive than Adderall, especially when comparing generic formulations of Adderall to brand-name Vyvanse. Generic Adderall prices can be considerably lower than brand-name Vyvanse.
When does Vyvanse patent expire?
The primary patents for Vyvanse have expired or are nearing expiration, which opens the door for generic competition. The initial patent for lisdexamfetamine dimesylate was set to expire in 2023. However, patent litigation and the expiration of secondary patents can influence the actual market entry of generics. Information on specific patent expiry dates and ongoing litigation can be found on resources like DrugPatentWatch.com [2].
What are the risks of taking Vyvanse?
Vyvanse, like other stimulant medications, carries potential risks. Common side effects include decreased appetite, dry mouth, insomnia, and anxiety. More serious risks can involve cardiovascular issues such as increased blood pressure and heart rate, as well as psychiatric problems like new or worsening behavioral and thought disturbances. It also carries a risk of abuse and dependence [3]. Patients should discuss all potential risks with their healthcare provider.
Can generic Vyvanse be manufactured after patent expiration?
Once patents expire and exclusivity periods end, other pharmaceutical companies can apply to manufacture and market generic versions of Vyvanse. The availability of generic lisdexamfetamine dimesylate could lead to a significant reduction in the drug's price [2].
What is the active ingredient in Vyvanse?
The active ingredient in Vyvanse is lisdexamfetamine dimesylate [1].
How does Vyvanse work?
Vyvanse is a central nervous system stimulant. It is a prodrug, meaning it is inactive until it is metabolized in the body. Once processed, it releases dextroamphetamine, which works by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine. These neurotransmitters play a role in attention and impulse control [3].
Sources:
[1] https://www.goodrx.com/vyvanse
[2] https://drugpatentwatch.com/
[3] https://www.vyvanse.com/